Dihexa (also known as PNB 0408) is an experimental small molecule derived from angiotensin IV. It was engineered to cross the bloodbrain barrier and has shown synaptogenic effects in preclinical models. The often quoted What if neuroplasticity research targeted the HGF c Met pathway? Dihexa (PNB 0408) is an angiotensin IVderived peptide studied in preclinical models for its role in synaptogenesis and cognitive signaling mechanisms. Human data remains limited. HGF c Met 1 integrin signalling axis induces tunneling nanotubes in A549 lung adenocarcinoma cells Life Science Alliance DIHEXA 30ML LIQUID (20MG ML, 600MG BOTTLE) UMBRELLA Labs Targeting the HGF MET axis in cancer: therapeutic promise for natural compounds ScienceDirect Dihexa Research Peptide Protocols: Reconstitution & Storage